I see that investors in Pfizer are stunned by a fall of more than ?15 billion in the value of the drug company after trials of the cholesterol-lowering drug Torcetrapib were stopped.
In clinical trials there were 60 per cent more deaths in the group taking the animal-tested drug than in the group given a placebo. Perhaps investors should support our campaign.
Pat Rattigan
Director, British Anti-Vivisection Association
Register to continue
Why register?
- Registration is free and only takes a moment
- Once registered, you can read 3 articles a month
- Sign up for our newsletter
Subscribe
Or subscribe for unlimited access to:
- Unlimited access to news, views, insights & reviews
- Digital editions
- Digital access to °Õ±á·¡¡¯²õ university and college rankings analysis
Already registered or a current subscriber? Login